Héctor Javier Sánchez | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Dr. Héctor Javier Sánchez | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Subject Professor | Technological University of Coahuila | Mexico

Dr. Héctor Javier Sánchez is an active materials science researcher whose work centers on the synthesis, characterization, and biomedical integration of magnetic nanomaterials. His contributions span more than a decade and encompass extensive research on ferrite-based nanoparticles engineered for hyperthermia therapy, diagnostic imaging, toxin adsorption, and multifunctional biomedical applications. His publication record includes numerous peer-reviewed articles in high-impact journals such as Ceramics International, Journal of Magnetism and Magnetic Materials, Journal of Materials Science: Materials in Medicine, Colloids and Surfaces A, and Journal of Alloys and Compounds. These works highlight advances in sol-gel synthesis, thermal decomposition, nanoparticle coating strategies, and the evaluation of structural, magnetic, heating, biocompatibility, and hemolysis properties of materials across systems such as Fe-Ga, Mn-Ga, Co-Ga, Mg-Mn, Mg-Zn, Ti-doped ferrites, and Zn-Mg ferrites. Dr. Héctor Javier Sánchez has also contributed to technological development projects focused on magnetic nanoparticle platforms for cancer hyperthermia, supported by innovation and government funding programs. His participation includes producing final technical reports and advancing R&D packages involving Fe-Ga-Co systems and biomedical coating methodologies for enhanced stability and therapeutic performance. His research dissemination extends to numerous international and national conferences, where he has presented over 30 contributions covering nanoparticle synthesis routes, crystallographic behavior, magnetic induction performance, cytotoxicity studies, and polymer–nanoparticle composites for advanced functional applications. He has also co-authored a book chapter published by the American Ceramics Society, addressing next-generation bioceramics and magnetic materials processing. Dr. Héctor Javier Sánchez’s work reflects a strong focus on innovation in nanomagnetism, bioceramics, and advanced materials engineering. With over 312 citations, 15 documents, and an h-index of 10 (Scopus), multiple collaborative projects, and recognized contributions to magnetic hyperthermia research, he continues to advance the frontier of nanotechnology-enabled biomedical solutions.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Reyes-Rodríguez, P. Y., Cortés-Hernández, D. A., Escobedo-Bocardo, J. C., Almanza-Robles, J. M., Sánchez-Fuentes, H. J., Jasso-Terán, A., De León-Prado, L. E., Méndez-Nonell, J., & Hurtado-López, G. F. (2017). Structural and magnetic properties of Mg–Zn ferrites (Mg₁₋ₓZnₓFe₂O₄) prepared by sol–gel method. Journal of Magnetism and Magnetic Materials, 427, 268–271. https://doi.org/10.1016/j.jmmm.2016.10.078

2. Jasso-Terán, R. A., Cortés-Hernández, D. A., Sánchez-Fuentes, H. J., Reyes-Rodríguez, P. Y., de-León-Prado, L. E., Escobedo-Bocardo, J. C., & Almanza-Robles, J. M. (2017). Synthesis, characterization and hemolysis studies of Zn₍₁₋ₓ₎CaₓFe₂O₄ ferrites synthesized by sol–gel for hyperthermia treatment applications. Journal of Magnetism and Magnetic Materials, 427, 241–244. https://doi.org/10.1016/j.jmmm.2016.10.099

3. Sánchez, J., Cortés-Hernández, D. A., Escobedo-Bocardo, J. C., Jasso-Terán, R. A., & Zugasti-Cruz, A. (2014). Bioactive magnetic nanoparticles of Fe–Ga synthesized by sol–gel for their potential use in hyperthermia treatment. Journal of Materials Science: Materials in Medicine, 25(10), 2237–2242. https://doi.org/10.1007/s10856-014-5197-1

4. De-León-Prado, L. E., Cortés-Hernández, D. A., Almanza-Robles, J. M., Escobedo-Bocardo, J. C., Sánchez, J., Reyes-Rodríguez, P. Y., Jasso-Terán, R. A., & Hurtado-López, G. F. (2017). Synthesis and characterization of nanosized MgₓMn₁₋ₓFe₂O₄ ferrites by both sol–gel and thermal decomposition methods. Journal of Magnetism and Magnetic Materials, 427, 230–234. https://doi.org/10.1016/j.jmmm.2016.11.036

5. Sánchez, J., Rodríguez-Reyes, M., Cortés-Hernández, D. A., Ávila-Orta, C. A., & Reyes-Rodríguez, P. Y. (2021). Heating capacity and biocompatibility of Pluronic-coated manganese gallium ferrites for magnetic hyperthermia treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 612, 125986. https://doi.org/10.1016/j.colsurfa.2020.125986

Assist. Prof. Dr. Efthymia Iliana Matthaiou | Nanobiotechnology Awards | Best Researcher Award

Assist. Prof. Dr. Efthymia Iliana Matthaiou | Nanobiotechnology Awards | Best Researcher Award

Assist. Prof. Dr. Efthymia Iliana Matthaiou, Albany Medical College, United States

Efthymia Iliana Matthaiou, PhD, is an Assistant Professor at Albany Medical College, NY, specializing in fungal infections and immunology. With a solid background in nanotechnology, immuno-oncology, and drug development, she leads cutting-edge translational research, developing novel therapies and diagnostics. Her expertise spans lung transplantation, cystic fibrosis, and autoimmune diseases. Dr. Matthaiou has a strong commitment to mentoring students, postdocs, and collaborators, and has been a key figure in advancing the study of fungal pathogens, including Aspergillus species. She holds several prestigious fellowships and grants, and has contributed significantly to scientific publications, particularly in the fields of immunology, transplantation, and nanomedicine.

Professional Profile:

Google Scholar

Orcid

Suitability for the “Best Researcher” Award: Efthymia Iliana Matthaiou, PhD

Summary of Suitability:

Dr. Efthymia Iliana Matthaiou is an exceptional candidate for the “Best Researcher” award due to her extensive and pioneering contributions in the fields of microbiology, immunology, and fungal infections. With a PhD from the University of Pennsylvania and Democritus University of Thrace, Dr. Matthaiou has advanced research into the molecular mechanisms of diseases such as cystic fibrosis and invasive fungal infections, focusing on immunomodulatory therapies and bioanalytical strategies.

🎓Education:

Dr. Matthaiou completed her postdoctoral training at Stanford University in 2020, focusing on lung immunology and transplantation. She earned her PhD from the University of Pennsylvania and Democritus University of Thrace in 2017, where her research centered on nanotechnology, immuno-oncology, and drug development. She graduated with the highest honors from Democritus University of Thrace with a BSc in 2011, marking the beginning of her promising scientific career.

🏢Experience:

Dr. Matthaiou is currently an Assistant Professor at Albany Medical College, where she leads a research laboratory focused on fungal infections and lung transplantation. Before this, she was a Lead Senior Scientist at Stanford University, leading several research initiatives on lung microenvironment, cystic fibrosis, and Aspergillus-related diseases. Her work includes developing immunomodulatory nanotherapies and studying host-pathogen interactions. She has also served as a postdoctoral researcher at Stanford, focusing on invasive aspergillosis in pediatric lung transplant patients and mentoring new hires and trainees.

🏅Awards and Honors:

Dr. Matthaiou has received several prestigious awards and fellowships, including the 2024 NCCAT-GUP3 Cryo-EM grant, for which she serves as Principal Investigator. She was also a Fellow of the 2022 Women’s Leadership Innovation Lab and received the 2019 Stanford MCHRI Postdoctoral Award, funding her research on innate immunity defects in cystic fibrosis and Aspergillus infections. These accolades highlight her leadership and contributions to the fields of immunology, transplantation, and infectious diseases.

🔬Research Focus:

Dr. Matthaiou’s research focuses on the intersection of fungal infections, immunology, and nanomedicine. Her work investigates the immune mechanisms that contribute to Aspergillus-related diseases, especially in the context of lung transplantation and cystic fibrosis. She is also exploring novel therapeutic approaches, such as nanoparticle-mediated drug delivery, to treat invasive aspergillosis. In addition, her research delves into macrophage dysregulation and its role in promoting fungal invasion, with the aim of developing immunomodulatory treatments to mitigate infection and improve patient outcomes.

Publication Top Notes:

  • Title: Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
    • Cited by: 89
  • Title: Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature
    • Cited by: 78
  • Title: Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis
    • Cited by: 40
  • Title: Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
    • Cited by: 36
  • Title: The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial
    • Cited by: 17